| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Mycobacterium Infections | D009164 | 7 associated lipids |
| Sarcoidosis | D012507 | 13 associated lipids |
| Hepatolenticular Degeneration | D006527 | 3 associated lipids |
| Hyperglycemia | D006943 | 21 associated lipids |
| Carcinoma, Squamous Cell | D002294 | 14 associated lipids |
| Skin Neoplasms | D012878 | 12 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jain A et al. | Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. | 2001 | Pediatr Transplant | pmid:11328546 |
| MacFarlane GD et al. | Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients. | 2001 | Pediatr Transplant | pmid:11328550 |
| Dobrolet NC et al. | Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. | 2001 | Pediatr Transplant | pmid:11328551 |
| Frühwirth M et al. | Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report. | 2001 | Pediatr Transplant | pmid:11328552 |
| Ogawa Y et al. | Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. | 2001 | Cornea | pmid:11333336 |
| pmid:11334064 | ||||
| Mackinnon SE et al. | Clinical outcome following nerve allograft transplantation. | 2001 | Plast. Reconstr. Surg. | pmid:11335811 |
| Parasrampuria DA et al. | A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function. | 2001 | Pharm. Res. | pmid:11336351 |
| Lee TH | Skin disease. Eczema. | 2001 | Harv Health Lett | pmid:11340028 |
| Obata K et al. | Role of FK506-binding protein 12 in development of the chick embryonic heart. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11341768 |
| De Bonis M et al. | Tacrolimus as a rescue immunosuppressant after heart transplantation. | 2001 | Eur J Cardiothorac Surg | pmid:11343954 |
| Treede H et al. | Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. | 2001 | J. Heart Lung Transplant. | pmid:11343977 |
| Yan M et al. | The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. | 2001 | FASEB J. | pmid:11344081 |
| Sutherland DE et al. | Pancreas transplantation for treatment of diabetes mellitus. | 2001 | World J Surg | pmid:11344403 |
| Skaehill PA | Tacrolimus in dermatologic disorders. | 2001 | Ann Pharmacother | pmid:11346066 |
| Kawamura I et al. | Induction of choleresis by immunosuppressant FK506 through stimulation of insulin-like growth factor-I production in the liver of rats. | 2001 | Eur. J. Pharmacol. | pmid:11348636 |
| Trotter JF et al. | Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. | 2001 | Liver Transpl. | pmid:11349259 |
| Ahuja M et al. | Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. | 2001 | Transplantation | pmid:11349723 |
| Pérgola PE et al. | Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. | 2001 | Transplantation | pmid:11349738 |
| Stover JF et al. | Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats. | 2001 | J. Neurosurg. | pmid:11354410 |
| Yang DY et al. | Simultaneous monitoring of extracellular glucose, pyruvate, lactate and glutamate in gerbil cortex during focal cerebral ischemia by dual probe microdialysis. | 2001 | J Chromatogr A | pmid:11355832 |
| Arima H et al. | Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. | 2001 | J Pharm Sci | pmid:11357172 |
| Sakuma S et al. | Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. | 2001 | Int. Immunopharmacol. | pmid:11357886 |
| Ebisu T et al. | Early and delayed neuroprotective effects of FK506 on experimental focal ischemia quantitatively assessed by diffusion-weighted MRI. | 2001 | Magn Reson Imaging | pmid:11358652 |
| Guo X et al. | Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. | 2001 | Eur. J. Neurosci. | pmid:11359520 |
| Lensmeyer GL and Poquette MA | Therapeutic monitoring of tacrolimus concentrations in blood: semi-automated extraction and liquid chromatography-electrospray ionization mass spectrometry. | 2001 | Ther Drug Monit | pmid:11360032 |
| Venkataramanan R et al. | Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. | 2001 | J Clin Pharmacol | pmid:11361051 |
| Wallemacq PE and Verbeeck RK | Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. | 2001 | Clin Pharmacokinet | pmid:11368293 |
| Otto KG et al. | Cell proliferation through forced engagement of c-Kit and Flt-3. | 2001 | Blood | pmid:11369667 |
| Morales JM et al. | Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. | 2001 | Nephrol. Dial. Transplant. | pmid:11369839 |
| Goldman D | Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. | 2001 | J. Am. Acad. Dermatol. | pmid:11369912 |
| Poirier SN et al. | FK506 blocks intracellular Ca2+ oscillations in bovine adrenal glomerulosa cells. | 2001 | Biochemistry | pmid:11371212 |
| Hashida T et al. | Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. | 2001 | Clin. Pharmacol. Ther. | pmid:11371998 |
| Mathis AS et al. | Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. | 2001 | Transplantation | pmid:11374405 |
| Jain A et al. | Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. | 2001 | Transplantation | pmid:11374410 |
| Neumann UP et al. | Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. | 2001 | Transplantation | pmid:11374419 |
| Yamamoto-Yamaguchi Y et al. | Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. | 2001 | Exp. Hematol. | pmid:11376870 |
| Paul LC | Overview of side effects of immunosuppressive therapy. | 2001 | Transplant. Proc. | pmid:11377462 |
| Ierardi E et al. | Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. | 2001 | Transplant. Proc. | pmid:11377467 |
| Bilbao I et al. | Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. | 2001 | Transplant. Proc. | pmid:11377472 |
| Braun F et al. | Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. | 2001 | Transplant. Proc. | pmid:11377473 |
| Gerbase MW et al. | Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. | 2001 | Transplant. Proc. | pmid:11377481 |
| Gerhardt U et al. | High QT dispersion in tacrolimus-treated kidney transplant recipients. | 2001 | Transplant. Proc. | pmid:11377482 |
| Hesse CJ et al. | The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. | 2001 | Transplant. Proc. | pmid:11377487 |
| Klupp J et al. | New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus. | 2001 | Transplant. Proc. | pmid:11377491 |
| McGrath JS and Shehata M | The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection. | 2001 | Transplant. Proc. | pmid:11377499 |
| McGrath JS and Shehata M | Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution. | 2001 | Transplant. Proc. | pmid:11377500 |
| Kelly JS and Sharkey J | Immunosuppressants-ligands as neuroprotectants. | 2001 | Transplant. Proc. | pmid:11377506 |
| Mohacsi P et al. | Immunosuppression in ABO-incompatible transplantation. | 2001 | Transplant. Proc. | pmid:11377508 |
| Jonas S et al. | Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy. | 2001 | Transplant. Proc. | pmid:11377511 |